Jose Alejandro Rauh-Hain Fernandez MD

Obstetrics & Gynecology•Houston, TX

Gynecologic Oncology

Assistant Professor Gynecologic Oncology and Reproductive Medicine, Health Services Research

Join to View Full Profile

1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161

Summary

I'm a Gynecologic Oncologist on staff at the University of Texas MD Anderson Cancer Center. I was born and raised in Mexico City, Mexico and received mymedical degree from Universidad Panamericana School of Medicine. After graduating from medical school, I accepted an opportunity to work as a research fellow at the Massachusetts General Hospital. I conducted basic science research in the laboratory and performed clinical studies looking for biomarkers for early detection of preeclampsia. Afterwards I was accepted in the combined Obstetrics and Gynecology Residency Program at the Massachusetts General Hospital and Brigham and Women's Hospital, Harvard Medical School. Following residency, I completed a fellowship in Gynecologic Oncology at the Massachusetts General Hospital, Harvard Medical School. I completed a Masters in Public Health (MPH) at the Harvard School of Public Health and a post-doctoral fellowship in the Program in Cancer Outcomes Research Training Program. I served as faculty member in the Division of Gynecologic Oncology the Massachusetts General Hospital and was an Assistant Professor at Harvard Medical School before joining the University of Texas MD Anderson Cancer Center. My interests include the surgical treatment of gynecologic malignancies and the management of rare gynecologic tumors. I'm also interested in descriptive and intervention research studies conducted in real-world clinical settings that may possibly reveal the effectiveness of strategies to reduce well-documented disparities in gynecological cancer and improve care of young women with cancer.

In cervical cancer surgery, minimally invasive is worse than open, study says

Among patients with early-stage cervical cancer, women who undergo minimally invasive operations have a greater risk of dying than those who undergo open surger

Minimally invasive surgery associated with worse survival for women with cervica

When comparing standard-of-care surgical options for women with early-stage cervical cancer, two studies led by researchers at The University of Texas MD Anders

Education & Training

Harvard School of Public HealthMPH, 2015 - 2017
Harvard School of Public HealthMPH, Clinical Effectiveness Tract, 2015 - 2017
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalResidency, Obstetrics and Gynecology, 2008 - 2012
Universidad Panamericana Escuela de MedicinaClass of 2005, MD, High Honors

Certifications & Licensure

FL State Medical License 2021 - Present
TX State Medical License 2017 - 2027
MA State Medical License 2012 - 2018
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Francoise Hermann Foundation/Massachusetts General Hospital Cancer Center Award Program Massachusetts General Hospital, Harvard Medical School, 2015
Fellow The Program in Cancer Outcomes Research Training Institute for Technology Assessment, Massachusetts General Hospital, Harvard Medical School, 2015
Resident Scholar Award Association of Professors in Obstetrics and Gynecology, 2010
Outstanding Teacher in Obstetrics and Gynecology Brigham and Women�s Hospital, Harvard Medical School, 2008-2010
High Honors Universidad Panamericana Medical School, 2005
Honors Sub-Internship Hospital Escandon, 2004
Sub-Intern of the Year Hospital Escandon, 2004
Chief Sub-Intern Hospital Escandon, 2003
Join now to see all

Publications & Presentations

PubMed

Disparities in facility-level adoption of minimally invasive interval debulking surgery for advanced ovarian cancer.
Roni Nitecki Wilke, Chi-Fang Wu, Alexa Kanbergs, Alexandra S Bercow, Nuria Agusti
Gynecologic Oncology. 2025-04-17
The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvan...
Roni Nitecki Wilke, Jinsong Liu, Shannon Neville Westin, Bryan M Fellman, Travis T Sims
International Journal of Gynecological Cancer. 2025-01-06
1 citations
Surgical Deescalation Within Gynecologic Oncology.
Alexa Kanbergs, Alexander Melamed, David Viveros-Carreño, Chi-Fang Wu, Roni Nitecki Wilke
JAMA Network Open. 2025-01-02

Journal Articles

Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies
Rauh-Hain JA, Melamed A**, Schaps D, Bregar AJ**, Spencer R, Schorge JO, Rice LW, del Carmen MG, Gynecol Oncol., 1/1/2018
Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all-cause mortality: a quasi-experimental study
Melamed A**, Fink G, Wright AA, Keating NL, Gockley AA**, del Carmen MG, Schorge JO, Rauh-Hain JA, BMJ, 1/1/2018
Modeling treatment outcomes for patients with advanced stage ovarian cancer: Projected benefits of test to optimize treatment selection
Weaver TD, Raphel TJ, Melamed A**, Rauh-Hain JA, Schorge JO, Knudsen AB, Pandharipande PV, Gynecol Oncol., 1/1/2018
Trends in place of death among gynecologic cancer patients in the United States
Hicks-Courant K, Melamed A**, Worley MJ, Bae Kim Y, Schorge JO, Rauh-Hain JA, Obstet Gynecol., 1/1/2018
Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
Rauh-Hain JA, N Engl J Med, 1/1/2018
Society of Gynecologic Oncology 2018 Annual Meeting on Women's Cancer: Meeting report
Rauh-Hain JA, Brewster WR, Behbakht K, Gynecol Oncol., 1/1/2018
Management and Treatment of Recurrent Epithelial Ovarian Cancer
Armbruster S, Coleman RL, Rauh-Hain JA, Hematol Oncol Clin N Am., 1/1/2018
Patient, treatment and discharge factors associated with hospital readmission within 30days after surgery for vulvar cancer
Dorney KM, Growdon WB, Clemmer JT**, Rauh-Hain JA, Hall TR, Diver E, Boruta D, Del Carmen MG, Goodman A, Schorge JO, Horowitz N, Clark RM, Gynecol Oncol., 1/1/2017
Staging for Apparent Stage I Epithelial Ovarian Cancer: Analysis of the National Cancer Data Base
Melamed A**, Keating NL, Clemmer JT**, Bregar AJ**, Wright JD, Boruta DM, Schorge JO, del Carmen MG, Rauh-Hain JA, Am J Obstet Gynecol., 1/1/2017
Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer
Rauh-Hain JA, Melamed A**, Wright A, Gockley A**, Clemmer JT**, Schorge JO, del Carmen MG, Keating NL, JAMA Oncol., 1/1/2017
Association of Hospital Volume on Racial and Ethnic Disparities in Locally Advanced Cervical Cancer
Uppal S, Chapman C, Spencer RJ, Jolly S, Maturen K, Rauh-Hain JA, del Carmen MG, Rice LW, Obstet Gynecol., 1/1/2017
Outcomes of Women With High-Grade and Low-Grade Advanced Stage Serous Epithelial Ovarian Cancer
Gockley A**, Melamed A**, Bregar AJ**, Clemmer JT**, Birrer M, Schorge JO, del Carmen MG, Rauh-Hain JA, Obstet Gynecol., 1/1/2017
Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy
Melamed A**, Nitecki R, Boruta DM, del Carmen MG, Clark RM, Growdon WB, Goodman A, Schorge JO, Rauh-Hain JA, Obstet Gynecol., 1/1/2017
Minimally Invasive Staging Surgery in Women with Early-Stage Endometrial Cancer: Analysis of the National Cancer Database
Bregar AJ**, Melamed A**, Diver E**, Clemmer JT**, Uppal S, Schorge JO, Rice LW, del Carmen MG, Rauh-Hain JA, Ann Surg Oncol., 1/1/2017
Disparities in Receipt of Care for High-Grade Endometrial Cancer: A National Cancer Database Analysis
Bregar AJ**, Rauh-Hain JA, Spencer R, Clemmer JT**, Schorge JO, Rice LW, del Carmen MG, Gynecol Oncol., 1/1/2017
All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer
Melamed A**, Rizzo AE, Nitecki R, Gockley A**, Bregar AJ**, Schorge JO, del Carmen MG, Rauh-Hain JA, Obstet Gynecol., 1/1/2017
Associations between residual disease and survival in epithelial ovarian cancer by histologic type
Melamed A**, Manning-Geist B, Bregar AJ**, Diver EJ**, Goodman A, del Carmen MG, Schorge JO, Rauh-Hain JA, Gynecol Oncol., 1/1/2017
Clinical Outcomes Research in Gynecologic Oncology
Melamed A**, Rauh-Hain JA, Schorge JO, Gynecol Oncol., 1/1/2017
Intraoperative Radiation Therapy in the Management of Gynecologic Malignancies
Foley OW**, Rauh-Hain JA, Clark RM, Goodman A, Growdon WB, Boruta DM, Schorge JO, Del Carmen MG, Am J Clin Oncol., 1/1/2016
Mucinous adenocarcinoma of the endometrium compared to endometrioid endometrial cancer: a SEER analysis
Rauh-Hain JA, Vargas R**, Clemmer J**, Clark RM, Growdon WB, Goodman AK, Boruta DM, Schorge JO, del Carmen MG, Am J Clin Oncol., 1/1/2016
Risk Factors for Occult Uterine Sarcoma among Women undergoing Minimally Invasive Gynecologic Surgery
Oduyebo T**, Hinchcliff EM**, Meserve EE, Seidman MA, Quade B, Rauh-Hain JA, George S, Nucci MR, del Carmen MG, Muto MG, J Minim Invasive Gynecol., 1/1/2016
Racial Disparities in Survival in Malignant Germ Cell Tumors of the Ovary
Hinchcliff EM**, Rauh-Hain JA, Clemmer J**, Diver E**, Hall T, Stall J, Growdon WB, Clark RM, Schorge JO, Gynecol Oncol., 1/1/2016
Patterns of Care, Predictors and Outcomes of Adjuvant Therapy for Early and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-based Analysis
Gockley AA**, Rauh-Hain JA, Meyer LA, Clemmer J**, Lu KH, Schorge JO, del Carmen MG, Int J Gynecol Cancer, 1/1/2016
Readmissions after Major Gynecologic Oncology Surgery
Uppal S, Penn C, Del Carmen MG, Rauh-Hain JA, Reynolds RK, Rice LW, Gynecol Oncol., 1/1/2016
The Role of Endometrial Biopsy in the Preoperative Detection of Uterine Leiomyosarcoma
Hinchcliff EM**, Esselen KM, Watkins JC, Oduyebo T**, Rauh-Hain JA, Del Carmen MG, Quade BJ, Muto MG, J Minim Invasive Gynecol., 1/1/2016
Join now to see all

Books/Book Chapters

Handbook for Principles and Practice of Gynecologic Oncology
Chapter: The Corpus: Epithelial tumors.
Page 153 - 183Rauh-Hain JA, Dizon DSEditors: Douglas A. Levine, Don S. Dizon, Catheryn M. Yashar, Richard R. Barakat, Andrew Berchuck, Maurie Markman, Marcus E. Randall.Wolters KluwerEdition Seco,2015
Uncommon Gynecologic Cancers
Chapter: Carcinosarcoma of the Ovary.
Page 109 - 119Rauh-Hain JA, del CarmenEditors: Marcela del Carmen, John O. Schorge, Robert H. Young.Wiley-Blackwell2014
Uncommon Gynecologic Cancers
Chapter: Uterine Clear Cell Carcinoma.
Page 186 - 194Rauh-Hain JA, Olawaiye AB, Boruta DMEditors: Marcela del Carmen, John O. Schorge, Robert H. Young.Wiley-Blackwell2014
Uncommon Gynecologic Cancers
Chapter: Endometrial Stromal Sarcomas.
Page 205 - 215Schmeler KM, Rauh-Hain JA, del CarmenEditors: Marcela del Carmen, John O. Schorge, Robert H. Young.Wiley-Blackwell2014
Uncommon Gynecologic Cancers
Chapter: Sarcomas of the Vulva and Vagina.
Page 236 - 243Clark RM, Rauh-Hain JA, del CarmenEditors: Marcela del Carmen, John O. Schorge, Robert H. Young.Wiley-Blackwell2014
Join now to see all

Abstracts/Posters

Minimally-invasive surgery in women with early-stage cervical cancer.
Rauh-Hain JA, 15th Annual Meeting on Breast Diseases, Merida, Mexico, 1/1/2018
Robotic Surgery Gynecological Cancers.
Rauh-Hain JA, MD Anderson Spain Gynecologic Oncology Conference, Madrid, Spain, 1/1/2018
Adjuvant treatments in uterine sarcomas.
Rauh-Hain JA, MD Anderson Spain Gynecologic Oncology Conference, Madrid, Spain, 1/1/2018
Comparative effectiveness of minimally-invasive surgery in women with early-stage cervical cancer.
Rauh-Hain JA, Selected Topics in Gynecologic Oncology Meeting, Cancun, Mexico, 1/1/2018
Health Services Research with Administrative Databases.
Rauh-Hain JA, 49th Annual Meeting on Women�s Cancer, New Orleans, LA, 1/1/2018
Variation of cost and resource utilization associated with the surgical management of women with ovarian cancer.
Rauh-Hain JA, 49th Annual Meeting on Women�s Cancer, New Orleans, LA, 1/1/2018
Comparative effectiveness of minimally-invasive surgery in women with early-stage cervical cancer.
Rauh-Hain JA, Late breaking abstract presented at 49th Annual Meeting on Women�s Cancer, New Orleans, LA, 1/1/2018
Prophylactic Surgery for Gynecological Cancers.
Rauh-Hain JA, International Gynecologic Oncology Course, Mexico City, Mexico, 1/1/2018
Fertility-sparing Surgery among Women with Ovarian Cancer.
Rauh-Hain JA, International Gynecologic Oncology Course, Mexico City, Mexico, 1/1/2018
Minimally-invasive surgery in women with early-stage cervical cancer.
Rauh-Hain JA, International Gynecologic Oncology Course, Mexico City, Mexico, 1/1/2018
Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all-cause mortality.
Rauh-Hain JA, AAOGF Scholarship retreat, Denver, CO, 1/1/2017
Adjuvant treatments in uterine sarcomas.
Rauh-Hain JA, Selected Topics in Gynecologic Oncology Meeting, Cancun, Mexico, 1/1/2016
Laparoscopic Staging for Stage I Ovarian Cancer: An Analysis of the National Cancer Database.
Rauh-Hain JA, 34th Annual New England Association of Gynecologic Oncologist Meeting, Kennebunkport, ME, 1/1/2015
Management and Outcomes for Elderly Women with High-Grade Endometrial Cancer.
Rauh-Hain JA, 34th Annual New England Association of Gynecologic Oncologist Meeting, Kennebunkport, ME, 1/1/2015
Massachusetts General Hospital Ovarian Cancer Outcomes: A Comparison with the MRC CHORUS Trial.
Rauh-Hain JA, 34th Annual New England Association of Gynecologic Oncologist Meeting, Kennebunkport, ME, 1/1/2015
Trends in Treatment of Uterine Serous Cancer in the Medicare Population.
Rauh-Hain JA, 34th Annual New England Association of Gynecologic Oncologist Meeting, Newport, RI, 1/1/2014
Trends in Treatment of Uterine Clear Cell Carcinoma in the Medicare Population.
Rauh-Hain JA, 34th Annual New England Association of Gynecologic Oncologist Meeting, Newport, RI, 1/1/2014
Racial disparities and Trends in Treatment of High-Grade Endometrial Cancer in the Medicare Population.
Rauh-Hain JA, 34th Annual New England Association of Gynecologic Oncologist Meeting, Newport, RI, 1/1/2014
Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared to fallopian tube cancer.
Rauh-Hain JA, 34th Annual New England Association of Gynecologic Oncologist Meeting, Newport, RI, 1/1/2014
Racial disparities and Trends in Treatment of High-Grade Endometrial Cancer in the Medicare Population.
Rauh-Hain JA, Society of Gynecologic Oncology Early Career Summit, Chicago, IL, 1/1/2014
Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time.
Rauh-Hain JA, 33rd Annual New England Association of Gynecologic Oncologist Meeting, Westbrook, CT, 1/1/2013
Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.
Rauh-Hain JA, 33rd Annual New England Association of Gynecologic Oncologist Meeting, Westbrook, CT, 1/1/2013
Platinum resistance in noeadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma.
Rauh-Hain JA, 32nd Annual New England Association of Gynecologic Oncologist Meeting, Bar Harbor, ME, 1/1/2012
Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer.
Rauh-Hain JA, 42nd Annual Meeting on Women�s Cancer, Orlando, FL, 1/1/2011
Clinical features and chemotherapy outcomes in adolescent patients with gestational trophoblastic neoplasia compare to adult women.
Rauh-Hain JA, 17th World Congress on Gestational Trophoblastic diseases, Budapest, Hungary, 1/1/2011
Join now to see all

Lectures

Early Detection of Ovarian Cancer
1/1/2016
How to get a manuscript published
Massachusetts General Hospital - 1/1/2016
Comparative Effectiveness Research in Gynecologic Oncology with the National Cancer Database (NCDB).
Birmingham, AL - 1/1/2016
Management of Abnormal Pap smears
Cooley Dickinson Hospital - 1/1/2015
Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: A Reasonable Option?
Brigham and Women�s Hospital - 1/1/2010
Deep Venous Thrombosis in Pregnancy
Massachusetts General Hospital - 1/1/2009
Vulvar Disease
Massachusetts General Hospital - 1/1/2009
Early Detection of Ovarian Cancer, Myth or Reality?
Brigham and Women�s Hospital - 1/1/2009
Join now to see all

Press Mentions

MD Anderson Research Highlights for March 27, 2025March 27th, 2025
March 27, 2025: Spotlight on Breakthroughs from MD Anderson ResearchMarch 27th, 2025